Since its founding in 2003 Stephan Köhler, proprietor and managing director, has specifically invested into companies within the field of medical engineering. Since its founding in 2003 Stephan Köhler, proprietor and managing director, has specifically invested into companies within the field of medical engineering. The first investment was in medi1one medical Großhandels GmbH
, which was sold after 5 years of strong growth and successful advancement. In 2013 the family business TRACOE medical GmbH
, which Stephan Köhler runs as managing director since 1990, was 100% integrated into the Group. In 2015 The Collectors’ Index
followed with a 10% share. Kapitex Healthcare Ltd
was acquired in 2016. In 2019 the Group grew even further: 25% of RegIntA GmbH
shares were acquired. A 27.5% stake in aedus Development GmbH
followed in 2020. 2021 brought changes on a large scale. On 1 October 2021 TRACOE medical
and Kapitex Healthcare Ltd
were sold to Atos Medica
l. Through the association of such powerful companies strategic co-operation, further internationalization, planning reliability and sound growth are strengthened and therefore the process to become "Global Players" in the field of tracheostomy is accelerated.
In early years already XTR Group invested in companies outside the field of medical engineering. Also in the future XTR Group GmbH is open for investments in all areas. The goal to invest into companies is, to further develop the firms under their own name and to advance to a sustainable internationally operative group of companies.